Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases.
Plaque radiotherapy for juxtapapillary choroidal melanoma: treatment complications and visual outcomes in 650 consecutive cases.
复制标题
斑块放射治疗近乳头脉络膜黑色素瘤:650 例连续病例的治疗并发症和视力结果。
作者:
M. Sagoo;C. Shields;J. Emrich;A. Mashayekhi;L. Komarnicky;J. Shields
IMPORTANCE
The treatment of juxtapapillary choroidal melanoma is challenging because of the proximity of the tumor to visually important structures.
OBJECTIVE
To report the complications of treatment of juxtapapillary choroidal melanoma with plaque radiotherapy.
DESIGN, SETTING, AND PARTICIPANTS
In this retrospective case series of patients from the Ocular Oncology Service, Wills Eye Hospital, 650 consecutive eyes with juxtapapillary choroidal melanoma (≤1 mm to optic disc) treated with plaque radiotherapy from October 1, 1974, through November 30, 2005, were studied.
MAIN OUTCOMES AND MEASURES
Kaplan-Meier analysis of rates of radiation complications, secondary enucleation, and visual acuity outcomes.
RESULTS
The 5-year (10-year) rate of nonproliferative retinopathy was 66% (75%); proliferative retinopathy, 24% (32%); maculopathy, 56% (65%); papillopathy, 61% (77%); cataract, 66% (80%); neovascular glaucoma, 15% (22%); vitreous hemorrhage, 35% (42%); and secondary enucleation, 16% (26%). Visual acuity of 20/200 or worse occurred in 54% (87%), and loss of more than 5 lines of Snellen visual acuity was found in 45% (78%).
CONCLUSIONS AND RELEVANCE
Among this case series, plaque radiotherapy for juxtapapillary choroidal melanoma commonly led to retinopathy and papillopathy, but globe retention was 84% at 5 years. Vision loss should be anticipated in 45% by 5 years. Plaque radiotherapy remains a suitable choice for the treatment of juxtapapillary melanoma with a high globe retention rate.
登录
查看更多内容
DOI:
10.1001/archopht.1985.01050110067027
发表时间:
1985
期刊:
Archives of ophthalmology (Chicago, Ill. : 1960)
影响因子:
--
作者:
Weinhaus,RS;Seddon,JM;Albert,DM;Gragoudas,ES;Robinson,N
通讯作者:
Robinson,N
影响因子:
13.7
作者:
Char,DH;Quivey,JM;Castro,JR;Kroll,S;Phillips,T
通讯作者:
Phillips,T
影响因子:
13.7
作者:
Boldt HC;Melia BM;Liu JC;Reynolds SM;Collaborative Ocular Melanoma Study Group
通讯作者:
Collaborative Ocular Melanoma Study Group
影响因子:
13.7
作者:
Melia,BM;Abramson,DH;Albert,DM;Boldt,HC;Earle,JD;Hanson,WF;Montague,P;Moy,CS;Schachat,AP;Simpson,ER;Straatsma,BR;Vine,AK;Weingeist,TA;CollaborativeOcularMelanomaStudyGroup
通讯作者:
CollaborativeOcularMelanomaStudyGroup
DOI:
10.1001/archopht.119.7.951
发表时间:
2001
期刊:
Archives of ophthalmology (Chicago, Ill. : 1960)
影响因子:
--
作者:
Diener-West,M;Earle,JD;Fine,SL;Hawkins,BS;Moy,CS;Reynolds,SM;Schachat,AP;Straatsma,BR;CollaborativeOcularMelanomaStudyGroup
通讯作者:
CollaborativeOcularMelanomaStudyGroup